Search research articles
Contact Us
Filters
Showing results (1-10 of 136) with videos related to
Page
of 14
Sort By:
Future Medicinal Chemistry
|
December 1, 2015
Can we design drugs for HIV/AIDS that are less susceptible to resistance?
Irene T Weber
Viruses
|
October 14, 2011
HIV-1 Protease: Structural Perspectives on Drug Resistance
Irene T Weber, Johnson Agniswamy
Current Pharmaceutical Design
|
May 17, 2007
The protease of human T-cell leukemia virus type-1 is a potential therapeutic target
József Tözsér, Irene T Weber
Future Medicinal Chemistry
|
August 10, 2017
Decoding HIV resistance: from genotype to therapy
Irene T Weber, Robert W Harrison
Postepy Biochemii
|
January 30, 2017
Tackling the problem of HIV drug resistance
Irene T Weber, Robert W Harrison
Apoptosis : an International Journal on Programmed Cell Death
|
August 6, 2009
Conformational similarity in the activation of caspase-3 and -7 revealed by the unliganded and inhibited structures of caspase-7
Johnson Agniswamy, Bin Fang, Irene T Weber
Mini Reviews in Medicinal Chemistry
|
October 16, 2008
Caspases: structure-guided design of drugs to control cell death
Irene T Weber, Bin Fang, Johnson Agniswamy
The FEBS Journal
|
August 19, 2007
Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis
Johnson Agniswamy, Bin Fang, Irene T Weber
Chemical Communications (Cambridge, England)
|
October 6, 2022
Beyond darunavir: recent development of next generation HIV-1 protease inhibitors to combat drug resistance
Arun K Ghosh, Irene T Weber, Hiroaki Mitsuya
Proceedings of the ... SIAM International Conference on Data Mining. SIAM International Conference on Data Mining
|
June 10, 2014
Sparse Representation for Prediction of HIV-1 Protease Drug Resistance
Xiaxia Yu, Irene T Weber, Robert W Harrison
Page
of 14
Search research articles
Search
Showing results (1-10 of 136) with videos related to
Sort By:
Page
of 14
Future Medicinal Chemistry
|
December 1, 2015
Can we design drugs for HIV/AIDS that are less susceptible to resistance?
Irene T Weber
Viruses
|
October 14, 2011
HIV-1 Protease: Structural Perspectives on Drug Resistance
Irene T Weber, Johnson Agniswamy
Current Pharmaceutical Design
|
May 17, 2007
The protease of human T-cell leukemia virus type-1 is a potential therapeutic target
József Tözsér, Irene T Weber
Future Medicinal Chemistry
|
August 10, 2017
Decoding HIV resistance: from genotype to therapy
Irene T Weber, Robert W Harrison
Postepy Biochemii
|
January 30, 2017
Tackling the problem of HIV drug resistance
Irene T Weber, Robert W Harrison
Apoptosis : an International Journal on Programmed Cell Death
|
August 6, 2009
Conformational similarity in the activation of caspase-3 and -7 revealed by the unliganded and inhibited structures of caspase-7
Johnson Agniswamy, Bin Fang, Irene T Weber
Mini Reviews in Medicinal Chemistry
|
October 16, 2008
Caspases: structure-guided design of drugs to control cell death
Irene T Weber, Bin Fang, Johnson Agniswamy
The FEBS Journal
|
August 19, 2007
Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis
Johnson Agniswamy, Bin Fang, Irene T Weber
Chemical Communications (Cambridge, England)
|
October 6, 2022
Beyond darunavir: recent development of next generation HIV-1 protease inhibitors to combat drug resistance
Arun K Ghosh, Irene T Weber, Hiroaki Mitsuya
Proceedings of the ... SIAM International Conference on Data Mining. SIAM International Conference on Data Mining
|
June 10, 2014
Sparse Representation for Prediction of HIV-1 Protease Drug Resistance
Xiaxia Yu, Irene T Weber, Robert W Harrison
Page
of 14